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Abstract
 
Adhesion of bone cells to the extracellular matrix is a crucial requirement for osteoblastic de-
velopment and function. Adhesion receptors connect the extracellular matrix with the cyto-
skeleton and convey matrix deformation into the cell. We tested the hypothesis that sex
hormones modulate mechanoperception of human osteoblastic cells (HOB) by affecting ex-
pression of adhesion molecules like fibronectin and the fibronectin receptor. Only dihydrotest-
osterone (DHT), but not 17
 
 
 
-estradiol, stimulated fibronectin (137%) and fibronectin receptor
(252%) protein expression. The effects of deformation strain on HOB metabolism were inves-
tigated in a FlexerCell
 
®
 
 strain unit. Cyclically applied strain (2.5% elongation) increased DNA
synthesis (125%) and interleukin-6 (IL-6) production (170%) without significantly affecting al-
kaline phosphatase (AP) activity, type I collagen (PICP), or osteoprotegerin (OPG) secretion.
10 nM DHT pretreatment abolished the mitogenic response of HOB to strain and increased
AP activity (119%), PICP (163%), and OPG production (204%). In conclusion, mechanical
strain stimulates bone remodeling by increasing HOB mitosis and IL-6 production. DHT en-
hances the osteoanabolic impact of deformation strain by increasing bone formation via in-
creased AP activity and PICP production. At the same time, bone resorption is inhibited by
decreased IL-6 and increased OPG secretion into the bone microenvironment.
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Introduction
 
Human bone cells are anchored to the organic bone matrix
via adhesion receptors of the integrin superfamily. Integrin
 
receptors are cell surface glycoproteins consisting of an
 
 
 
-chain  that is noncovalently linked to a 
 
 
 
-chain (1).
Among the various subunits, 
 
 
 
5 and 
 
 
 
1 are the most com-
mon integrins of bone cells that constitute the fibronectin
receptor (FNR) (2). FNRs of human bone cells interact
with abundant bone matrix proteins like fibronectin (FN)
and type I collagen via a minimal tripeptide sequence (Arg-
Gly-Asp) (1, 3). They connect the extracellular matrix to
the actin cytoskeleton via cytoskeleton-associated proteins
(4). Deformation strain of bone tissue by external mechani-
cal stress can thus be transformed into morphological
changes of the cytoskeleton and of cellular shape (5).
Therefore, integrins are excellent candidates for mechano-
receptors of bone, physically connecting the extracellular
bone matrix via actin-associated proteins within focal adhe-
sions with cytoskeletal microfilaments. This physical link
between extracellular matrix and the cytoskeleton enables
osteoblasts to respond more rapidly to deformation strain
than could be provided by any diffusion-based signaling
system. Mechanotransduction via the 
 
 
 
1-integrin subunit
enhances tyrosine phosphorylation of proteins physically
associated with the cytoskeleton and increases the activa-
tion of the focal adhesion kinase (FAK) and mitogen-acti-
vated protein (MAP) kinase (6). Therefore, mechanotrans-
duction via 
 
 
 
1-integrins may affect metabolic functions of
human osteoblastic cells (HOB) that are anchored to the
organic bone matrix when external mechanical strain is ex-
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erted onto bone tissue. Interestingly, the application of cy-
clic deformation strain to human osteoblastic cells in vitro
increased cell number and collagen production (7), which
provides a physiological basis for the positive impact of me-
chanical strain on bone metabolism. Several years ago,
Harold Frost (8) advanced the hypothesis that postmeno-
pausal bone loss is the consequence of an impaired ability
of bone tissue to perceive the osteoanabolic impact of me-
chanical strain (8). Frost’s hypothesis implies that sex ste-
roids modulate the sensitivity of bone tissue to perceive
mechanical strain, which may be due to an involvement of
sex steroid receptors in the adaptive responses of osteoblasts
to mechanical strain (9, 10). The observation of decreased
bone density in long distance running athletes with amen-
orrhea compared with eumenorrheic athletes is consistent
with an important osteoanabolic interaction of mechanical
strain and sex steroids (11). In this paper, we tested the pos-
sibility that sex steroids regulate the response of human os-
teoblastic cells to deformation strain by improving osteo-
blastic anchorage via stimulating gene expression of the
most abundant osteoblastic adhesion molecule, the FNR.
 
Materials and Methods
 
Cells.
 
Primary HOB were obtained from femoral bone biop-
sies of healthy adults who underwent trauma surgery (12). Cells
originating from male and female donors, unless otherwise stated,
were cultured in DMEM supplemented with 10% (vol/vol) new-
born calf serum, and 1% (vol/vol) penicillin/streptomycin. This
work was approved by the local ethics commission of the Uni-
versity of Heidelberg.
 
Stock Solutions and In Vitro Incubation.
 
10-mM stock solu-
tions of 5
 
 
 
-dihydrotestosterone (DHT) and 17
 
 
 
-estradiol (E2;
Sigma-Aldrich) were prepared in ethanol. PP1 (Alexis Biochemi-
cals) was dissolved in DMSO as a 10-mM solution. All experi-
ments were performed in phenol red–free and serum-free
DMEM. The maximal final solvent concentration was 0.005%.
 
Measurement of FN and FNR Expressed by HOB In Vitro.
 
HOB of both genders were grown in the presence of either DHT
or E2 (1–100 nM) for 72 h. Triton extracts (0.1% Triton X-100
in 12.5 mM Tris, 12.5 mM NaHCO
 
3
 
, and 0.01% sodium azide,
pH 7.0) were analyzed for FN using a fibronectin EIA kit
(TaKaRa Shuzo Co., Ltd) and normalized to cellular protein
content (nanogram FN per milligram protein). Protein was quan-
tified using the BCA protein assay kit (Pierce Chemical Co.).
The 
 
 
 
1 subunit of the FNR was quantified with a fibronectin re-
ceptor EIA kit (TaKaRa Shuzo Co., Ltd) and also normalized to
cellular protein (nanogram FNR per milligram protein).
 
Indirect Immunofluorescence.
 
For indirect immunofluorescence,
HOB were seeded on glass slides and grown to 75% confluence.
Cells were treated with 10 nM DHT or the solvent for 24 h and
fixed in ice-cold 80% methanol for 5 min, followed by incuba-
tion in acetone (5 min). The primary antibody, specific for 
 
 
 
1-
integrin (CHEMICON International, Inc.), was applied over-
night at 4
 
 
 
C. Cells were washed in PBS and incubated with a
fluorochrome-conjugated antibody (MoBiTec) for 1 h at room
temperature. Slides were photographed using a Leica DMRE
microscope.
 
RNA Isolation and Northern Blot.
 
Total RNA was isolated
from cultured HOB of male and female donors using the TRIzol
 
®
 
method (GIBCO BRL). 15 
 
 
 
g RNA/lane was separated on a
1.2% formaldehyde-MOPS agarose gel and transferred to Hy-
bond™-N (Amersham Biosciences). The cDNA probes were
prepared by reverse transcription of total RNA (Thermoscript;
GIBCO BRL) followed by a gene-specific PCR. Primer se-
quences for FNR amplification (
 
 
 
1 subunit) were as follows: for
FNR-F, 5
 
 
 
-ATCCCAGAGGCTCCAAAGATA-3
 
 
 
; and for
FNR-R, 5
 
 
 
-TGGTGCAGTTCTGTTCACTTG-3
 
 
 
 (GIBCO
BRL). Annealing was performed at 47
 
 
 
C. Expected fragment size
was 399 bp. Primers for GAPDH amplification were as follows:
for GAPDH-F, 5
 
 
 
-ACCACAGTCCATGCCATCAC-3
 
 
 
 and for
GAPDH-R, 5
 
 
 
-TCCACCACCCGTTTGCTGTAG-3
 
 
 
 (Sigma-
Aldrich). Annealing temperature was 58
 
 
 
C. Expected fragment
size was 450 bp. DNA probes were denatured and labeled with
 
 
 
-[
 
32
 
P]-dCTP (Amersham Biosciences) using the Prime-a-Gene
labeling kit (Promega). Hybridization and evaluation of autoradio-
graphs were performed as described previously (12).
 
Western Blot Analysis.
 
HOB from male and female donors
were grown to 90% confluence and lysed with 1 mM sodium
orthovanadate, 1% SDS, and 10 mM Tris, pH 7.4. Extracts were
denatured and mixed 1:2 with loading buffer (160 mM Tris-HCl,
pH 6.9, 20% glycerol, 4% SDS, 200 mM dithiothreitol, and
0.01% bromophenol blue). 30 
 
 
 
g protein/lane was separated on
an SDS-PAGE gel and transferred to Hybond™-P (Amersham
Biosciences). After blocking with 5% nonfat dry milk in TBS-T
(Tris-buffered saline, pH 7.6, 0.1% Tween 20), the membrane
was incubated with the antiintegrin 
 
 
 
1-antibody (Transduction
Laboratories), followed by thorough rinsing in TBS-T and treat-
ment with the peroxidase-linked secondary antibody (Amersham
Biosciences). Chemiluminescent detection was performed with
the ECL™ 
 
  
 
Plus reagent (Amersham Biosciences).
 
Adhesion of HOB to FN-coated Plates.
 
HOB of both genders
were treated with 1–100 nM DHT or the solvent for 72 h. Cells
were scraped off the dish and plated onto FN-coated 6-well
plates. 4 h later, nonadherent cells were removed by rinsing the
wells twice with PBS. Adherent cells were trypsinized and
counted in a hemocytometer.
 
Binding of FN-coated Latex Beads to HOB.
 
Latex beads (11.9–
25.7 
 
 
 
m in diameter; Sigma-Aldrich) were coated with 2 mg
FN/ml PBS for 24 h and added to the DHT- or solvent-treated
cultures at a density of 1,000 cells/well (in 24-well plates). After
4 h, supernatants together with unbound latex beads were re-
moved and cells were washed with PBS. 1 M NaOH was added
and the remaining latex beads were counted in a hemocytometer.
 
Application of Deformation Strain.
 
Application of deformation
strain was performed with a Flexercell
 
®
 
 strain unit (model FX-
4000™; Flexcell International). This system uses a vacuum to ap-
ply defined deformation to cells attached on flexible-bottomed
6-well plates coated with type I collagen (BioFlex
 
®
 
). Male HOB
cultures were plated at a density of 100,000 cells/well. After 24 h,
the medium was changed and the plates, containing a uniformly
distributed cell layer within each well, were inserted into the
baseplate of the strain device and strained according to the pro-
grammed regimen. Control plates were left unstrained for the
same period of time. Strain (2.5% elongation 
 
 
 
 25,000 
 
 
 
strain 
 
 
 
17 kPa) was intermittently applied (1-h strain, 3-h rest) for 48 h
in a sinus wave with 5-s increase and 5-s decrease. The results are
expressed in percentages of the unstrained controls 
 
 
 
 SD. Pre-
treatment with 10 nM DHT was performed for 24 h. 25 ng/ml
PP1 was directly added into the medium before strain applica-
tion. The compounds were present during the following 48-h
experimental period.
 
DNA Synthesis Assay.
 
6 h before the end of the strain regi-
men, 2 
 
 
 
Ci/ml methyl-[
 
3
 
H]thymidine (NEN Life Science Prod- 
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ucts) was added to each well and the regimen was continued.
Cells were washed with PBS and lysed with 0.25 M NaOH. In-
corporated tritium was determined in a scintillation counter and
is expressed as counts per minute/well.
 
Alkaline Phosphatase Activity.
 
Cells were lysed with 500 
 
 
 
l
Triton buffer/well. The alkaline phosphatase (AP) activity was
determined by mixing 50 
 
 
 
l Triton extract, 50 
 
 
 
l H
 
2
 
O, and 200
 
 
 
l of a solution containing 30 mM paranitrophenylphosphate,
150 mM bicarbonate buffer, and 1 mM MgCl
 
2
 
, pH 10.3. We
measured the change in absorbency at 405 nm against a refer-
ence wavelength of 492 nm after 30-min incubation at 37
 
 
 
C.
The specific AP activity is expressed in milliunits per milligram
of cellular protein.
 
Type I Procollagen Peptide Secretion.
 
Type I procollagen pep-
tide (PICP) released into the culture medium was determined as a
parameter for type I collagen synthesis. It was quantified in the
supernatants of HOB cultures using a PICP [
 
125
 
I]-labeled radio-
immunoassay kit (Orion Diagnostica). The remaining cell layer
was rinsed with PBS and dissolved by the addition of Triton
buffer. Secreted PICP is expressed as nanogram per milligram of
cellular protein.
 
Osteoprotegerin and IL-6.
 
Quantitative determination of se-
creted osteoprotegerin (OPG) was conducted using an OPG-
ELISA assay kit (Immundiagnostik). IL-6 was quantified in the
medium using an IL-6 ELISA assay kit (R&D Systems). Both gly-
coproteins are expressed as picogram per milligram cellular protein.
 
Results
 
Effects of DHT and E2 on FN and FNR Expression.
 
First, we examined the effects of DHT and E2 on FN and
FNR expression to test the possibility that sex steroids af-
fect osteoblastic anchorage. DHT (Table I) but not E2 (not
depicted) dose-dependently stimulated FN and FNR syn-
thesis in male and female cells. The potent stimulation of
FNR protein expression by DHT is visualized in Fig. 1. In
solvent-treated HOB cultures, functional active integrin 
 
 
 
1
subunit of FNR was faintly detectable and the fluorescence
appeared in an array-like pattern within the cytoplasm or at
the cell margins, respectively (Fig. 1 A). In marked con-
trast, DHT-stimulated cultures exhibited a more pro-
nounced fluorescent signal. Herein, integrin 
 
 
 
1 immu-
nolocalization clearly decorated the cytoplasm (Fig. 1 B),
suggesting an enhancement of ligand engagement of the in-
tegrin at the cell undersurface.
Because DHT increased FNR gene expression in HOB
cultures in vitro, we reasoned that untreated primary HOB
isolated from male donors (with higher androgen levels
compared with females) ex vivo also exhibit a higher FNR
gene expression than HOB from female donors. Indeed,
male HOB expressed significantly higher FNR mRNA and
FNR protein levels compared with female HOB (Fig. 2).
 
Effect of DHT on Adhesion of HOB to FN-coated Sur-
faces.
 
To test the functional significance of an increased
FNR gene expression, we determined the number of
HOB adhering to FN-coated culture vessels after pretreat-
ment with DHT for 72 h. DHT dose-dependently in-
creased the number of cells adhering to the FN-coated sur-
face (Table II). In addition, DHT pretreatment significantly
increased the number of FN-coated latex beads adhering to
HOB (Table II), indicating enhanced anchorage of HOB
to FN-coated surfaces.
 
Table I.
 
Effects of DHT Treatment (72 h) on FN and FNR 
Production by HOB 
 
DHT FN FNR
 
nM % control 
 
 
 
 SD % control 
 
 
 
 SD
 
1  110 
 
 
 
 5  158 
 
 
 
 4
 
a
 
10 130 
 
 
 
 12
 
a
 
226 
 
 
 
 15
 
a
 
100  137 
 
 
 
 7
 
a
 
252 
 
 
 
 21
 
a
 
The results are representative for male and female HOB. Control: for
FN, 30 ng/mg protein; for FNR, 7.5 
 
 
 
 1.2 ng/mg protein. Mean 
 
 
 
SD, 
 
n
 
 
 
 
 
 6.
 
a
 
P 
 
 
 
 0.01.
Figure 1. Detection of functional active  1-integrin in HOB from a 39-yr-old man by indirect immunofluorescence. While in solvent-treated cells,
the  1 subunit was faintly detectable at the perinuclear region and the cytoplasm and cell margins, respectively (A, arrowheads), fluorescence appeared re-
inforced after 24-h DHT (10 nM) treatment (B, arrowheads). Bar, 25  m. 
1390
 
DHT Modulates the Effects of Mechanical Strain
 
Effects of Elongation Strain on HOB Metabolism with/with-
out DHT Pretreatment.
 
HOB from male individuals were
used for the following experiments because male HOB
possess higher FNR gene expression than female cells (Fig.
2), and a tight attachment appears crucial for the subse-
quent strain application experiments. The cultures were
exposed to 2.5% elongation strain in order to study the ef-
fects of androgens on the osteoblastic response induced by
cellular deformation. This strain pattern stimulated DNA
synthesis and had a potent stimulatory effect on the IL-6
production, both evidence for a high turnover state of
bone metabolism, whereas there were no significant effects
on AP activity, type I collagen, and OPG production (Fig.
3, I). However, pretreatment with 10 nM DHT markedly
reduced the stimulatory effects of elongation strain on
DNA synthesis and IL-6 production but increased AP ac-
tivity, type I collagen, and OPG secretion (Fig. 3, II). The
presence of the specific FAK inhibitor PP1 (Fig. 3, III) en-
hanced DNA synthesis but abolished the stimulatory effects
of DHT pretreatment plus strain on AP, PICP, and OPG
and did not affect IL-6 secretion. Interestingly, when re-
peating these experiments using female HOB, we did not
observe reproducibly significant effects (unpublished data).
 
Discussion
 
This paper demonstrates a novel mechanism whereby
androgens modify the impact of mechanical strain by di-
recting bone metabolism from a high turnover and, there-
fore, bone-losing state into an osteoanabolic process. On
the molecular level, DHT induces gene expression of the
fibronectin receptor and its ligand, fibronectin, thereby en-
hancing anchorage of osteoblastic cells to the organic bone
matrix (13). This effect is androgen dependent because we
did not find a consistent stimulatory effect of E2 on FNR
or FN production in male and female osteoblastic cell cul-
tures, although HOB of both genders possess similar num-
bers of estrogen and androgen receptors (12, 14). How-
ever, if androgens stimulate FNR gene expression in HOB
in vitro, male-derived primary HOB ex vivo should ex-
press higher FNR levels than female-derived HOB due to
10-fold higher androgen serum levels in men (female DHT
serum levels range 
 
 
 
1 nM). We found, indeed, signifi-
cantly higher FNR mRNA and protein levels in primary
male HOB compared with female-derived, age-matched
HOB. Therefore, androgens stimulate FNR gene expres-
sion in HOB of both genders but due to the higher andro-
gen serum levels in men, male HOB possess a greater num-
ber of FNR.
Regulation of FNR-mediated cellular anchorage to the
extracellular matrix by sex steroids has also been observed
in other mesenchymal tissues (15). Disturbance of the ex-
tracellular matrix composition impairs the susceptibility of
bone tissue to perceive mechanical loading (16). Anchorage
of bone cells to the extracellular matrix is a prerequisite for
integrin-mediated signal transduction that affects osteoblas-
tic differentiation and supports osteoblastic survival (17,
Figure 2. Comparison of FNR mRNA (Northern blot) and protein
(Western blot) expression in primary HOB from five male and seven fe-
male donors, respectively. Mean   SD, unpaired two-tailed t test. *, P (of
male vs. female level)   0.05.
 
Table II.
 
Effects of DHT Treatment (72 h) on HOB Adhesion to 
FN-coated Surfaces and on Binding of FN-coated Latex Beads to 
HOB Cultures 
 
DHT
HOB adhesion to
FN-coated plates
Binding of FN-coated
latex beads to HOB
 
nM % control   SD % control   SD
1 182   10a 126   9a
10 184   22a 140   8a
100 254   21a 161   13a
The results are representative for male and female HOB. Control: for
HOB adhesion, 96,700   8,200 cells; for latex beads, 119   9 beads.
Mean   SD, n   6.
aP   0.01.
Figure 3. Effect of intermittently applied elongation strain (2.5%; 1-h
strain, 3-h rest for 48 h) on HOB metabolism in vitro. Cells were sub-
mitted to strain either without any pretreatment (I), pretreatment with 10
nM DHT for 24 h (II), or pretreatment with DHT and 25 ng/ml PP1
(III), respectively. Mean   SD (n   6), unpaired two-tailed t test, *, P  
0.05; **, P   0.01; ***, P   0.001. (a) Strained cultures (I) versus un-
strained controls. (b) DHT pretreatment (II) versus non–DHT-treated
cells (I). (c) DHT   PP1 pretreatment (III) versus DHT pretreatment (II).1391 Liegibel et al. Brief Definitive Report
18). The  1-integrin subfamily is crucial for the develop-
ment of stromal precursor cells into functional osteoblast-like
cells (19). There is also evidence for an interaction between
the postreceptor signaling pathway of bone morphogenetic
proteins and collagen–integrin-dependent signaling (20).
Therefore, the observed induction of the FNR gene by an-
drogens may enhance paracrine signaling by growth factors
of the TGF  family in the bone microenvironment. Im-
portantly, androgens elicit part of their positive effects on
bone metabolism by stimulating the expression of the
TGF 2 gene in human bone cells (21) and growth factors
of the TGF  family have been shown to elevate gene ex-
pression of fibronectin and adhesion protein receptors (22).
The observation that the application of both testosterone
and TGF 2 are effective in the prevention of unloading-
induced osteopenia (23, 24) lead us to investigate whether
mechanoperception of bone cells is affected by androgens.
This work and other authors (25) demonstrate that defor-
mation strain is mitogenic for osteoblastic cells and stimu-
lates IL-6 production, which suggests a stimulation of bone
remodeling because paracrine IL-6 secretion induces osteo-
clastogenesis (7, 26) and, due to the stimulation of osteo-
blastic cell growth, resorbed bone can be replaced effec-
tively. If androgens increase the number of FNR on the
osteoblastic cell surface and at least some of the effects of
deformation strain on bone cell metabolism are mediated
via integrin-associated signaling (27), then one might ex-
pect a quantitatively increased response of HOB to defor-
mation after androgen treatment. Surprisingly, androgen
treatment of male HOB does not induce a quantitatively
increased response, but qualitatively shifts the osteoblastic
response pattern. Androgen pretreatment inhibits the mito-
genic and stimulates the AP response to deformation strain
and allows HOB to secrete significantly increased amounts
of collagen type I and osteoprotegerin. OPG as the soluble
decoy receptor for the osteoblastic cell surface protein
RANKL inhibits osteoclastic bone resorption by intercept-
ing with the RANK–RANKL system (28). The androgen-
induced increase of OPG production and simultaneous de-
crease of IL-6 secretion by strained HOB implicate a potent
inhibition of bone resorption. Simultaneously, androgens
enable HOB to respond to deformation strain with an in-
creased AP activity and collagen I production, which indi-
cates increased bone formation. Considering the observed
enhanced anchorage of male HOB to the bone matrix due
to higher androgen serum levels in men, it is possible that
the development of a higher mean peak bone mass in men
(29) is, at least partly, due to this enhanced anchorage of
HOB in male bone.
Bone cell growth is regulated by several kinases (30),
whereby a specific integrin function in regulating responses
of human bone cells to mechanical strain via tyrosine ki-
nases and MAP kinases has been demonstrated (31).
Stretch-triggered induction of MAP kinase cascades stimu-
lates DNA binding activity of the bone-specific transcrip-
tional regulator Cbfa1 (32), which has a pivotal role in
osteoblast function (31). These findings indicate that osteo-
blastic deformation activates multiple integrin-associated
signaling pathways. To further elucidate the specific inte-
grin function in osteoblastic mechanoperception and its
modulation by androgens, we added an inhibitor that
blocks signaling by FAKs (33) while HOB cultures were
exposed to deformation strain. Inhibition of integrin-medi-
ated signaling via FAK enhanced the mitogenic effect after
DHT treatment but decreased the positive effect of osteo-
blastic deformation on AP, PICP, and OPG production
and did not affect IL-6 secretion. Thus, FAK activity is re-
quired for the enhanced AP, PICP, and OPG production
of strained HOB but not for the mitogenic response or for
the decreased IL-6 secretion induced by deformation strain.
Possibly, the promoter regions of the AP, OPG, and col-
lagen gene possess force-responsive elements that bind
transcription factors activated by FAK activity (34).
These in vitro observations indicate that androgens in
vivo may have a modulatory role in the regulation of bone
cell metabolism, whereby androgens gear the impact of
mechanical strain on bone metabolism from remodeling
into an osteoanabolic mode. As a corollary, these findings
may also help to understand the high turnover state of
bone metabolism induced by castration (26, 35). However,
a clinical study is required to address the long-term effects
of combined load and androgen treatment on bone tissue
in vivo.
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